...and that's just ONE application. Timely and crucial as it is.
We have families of patents and several other applications on the launch pad. Lower back pain and congested heart for starters. aGVHD also.
It's mind boggling how supposedly the best minds in Australian investing like Alan Kohler cannot get their heads around it.
I think it's probably insularity, not truly understanding biotechs and the size of the markets involved here. Too hard.
MSB Trading - 2020, page-17764
-
- There are more pages in this discussion • 5,397 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.050(3.83%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $21.32M | 17.21M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5460 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 978 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |